Stocks and Investing Stocks and Investing
Tue, March 2, 2021
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $45 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Paul Holden Upgraded (BNS) to Buy on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Ebrahim Poonawala Upgraded (BMO) to Strong Buy on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Jason Bazinet Upgraded (TRIP) to Strong Buy and Increased Target to $62 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Marvin Fong Upgraded (TRUE) to Strong Buy on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Nick Konstantakis Upgraded (TS) to Hold on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Paul Golding Upgraded (CCL) to Buy on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Mike Mayo Maintained (USB) at Buy with Increased Target to $60 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Daina Graybosch Initiated (BOLT) at Buy and Held Target at $36 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Matthew Harrison Initiated (BOLT) at Buy and Held Target at $45 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Michael Schmidt Initiated (BOLT) at Strong Buy and Held Target at $42 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Stephen Willey Initiated (BOLT) at Strong Buy and Held Target at $40 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Manav Patnaik Downgraded (ADT) to Sell and Decreased Target to $8 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Alex Henderson Downgraded (AAOI) to Hold on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Ryan Koontz Maintained (ZM) at Hold with Increased Target to $400 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Meta Marshall Maintained (ZM) at Hold with Increased Target to $420 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
James Fish Upgraded (ZM) to Buy and Increased Target to $541 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Arvind Ramnani Maintained (AI) at Buy with Decreased Target to $141 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Jack Andrews Maintained (AI) at Strong Buy with Increased Target to $195 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Daniel Ives Maintained (AI) at Buy with Decreased Target to $175 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
David Hynes Maintained (AI) at Hold with Decreased Target to $120 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Brandon Nispel Upgraded (AKAM) to Buy and Held Target at $119 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Graig Suvannavejh Initiated (TERN) at Strong Buy and Held Target at $29 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Ritu Baral Initiated (TERN) at Buy on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Eric Joseph Initiated (TERN) at Buy and Held Target at $32 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Michael Petusky Upgraded (XRAY) to Buy and Held Target at $71 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Paul Knight Maintained (XGN) at Buy with Increased Target to $33 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Thomas Allen Maintained (XHR) at Sell with Increased Target to $14 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Marc Goodman Maintained (XENE) at Buy with Increased Target to $28 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Serge Belanger Maintained (XENE) at Strong Buy with Increased Target to $25 on, Mar 2nd, 2021

Serge Belanger Maintained (XENE) at Strong Buy with Increased Target to $25 on, Mar 2nd, 2021


Published on 2024-10-27 15:49:06 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Maintained "Xenon Pharmaceuticals Inc." (XENE) at Strong Buy with Increased Target from $22 to $25 on, Mar 2nd, 2021.

Serge, nor any peers, have made any analyst calls on XENE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources